ABSTRACT
OBJECTIVE: To evaluate the reproducibility of the sentinel lymph node (SLN) technique in male breast cancer. MATERIAL AND METHODS: We retrospectively analysed 21 male patients diagnosed with breast cancer in our hospital from 2008 to 2016 with, at least, 18 months follow-up. Fifteen patients underwent selective sentinel lymph node biopsy (SLNB) following the usual protocols with peritumoral injection of 18.5-111MBq of 99mTc-nanocoloides and acquisition of planar images 2hours after the injection. In 2 cases it was necessary to perform a SPECT/CT to locate the SLN. Immunohistochemistry and molecular techniques (OSNA) were used for their analysis. Six patients did not undergo SLNB because they had pathological nodes or distant disease at the time of diagnosis. RESULTS: SLNB was performed in 15 patients. The SLN was negative in 6 patients and positive in the remaining 9. Three patients with positive SLNB did not need axillary lymphadenectomy because of the low number of copies by molecular analysis OSNA. Axillary lymphadenectomy was performed in the remaining 6 patients with the result of 4 positive axillary lymphadenectomies and 2 that did not show further extension of the disease. CONCLUSIONS: According to our experience, SLNB in males is a reproducible, useful, safe and reliable technique which avoids unnecessary axillary lymphadenectomy and prevents the appearance of undesirable effects.
Subject(s)
Breast Neoplasms, Male/pathology , Lymphatic Metastasis/diagnostic imaging , Lymphography/methods , Sentinel Lymph Node Biopsy/methods , Single Photon Emission Computed Tomography Computed Tomography , Aged , Aged, 80 and over , Axilla , DNA, Neoplasm/analysis , Humans , Lymph Node Excision , Male , Nucleic Acid Amplification Techniques , Radiopharmaceuticals , Reproducibility of Results , Retrospective Studies , Technetium Tc 99m Aggregated Albumin , Unnecessary ProceduresABSTRACT
No disponible
Subject(s)
Humans , Female , Middle Aged , Cecal Diseases/complications , Intestinal Obstruction/etiology , Intestinal Volvulus/complicationsABSTRACT
No disponible
Subject(s)
Female , Aged , Humans , Carcinoma, Lobular/pathology , Intestinal Obstruction/etiology , Breast Neoplasms/pathology , Ileal Neoplasms/secondary , Neoplasm Metastasis/pathologyABSTRACT
No disponible
Subject(s)
Male , Aged , Humans , Intestinal Fistula/diagnosis , Aorta/physiopathology , Duodenum/physiopathology , Hematemesis/etiology , Hypovolemia/etiologyABSTRACT
No disponible
Subject(s)
Middle Aged , Male , Humans , Biological Dressings , Tomography, X-Ray Computed , Postoperative Complications , Adhesives , Esophageal FistulaABSTRACT
OBJECTIVE: To review our experience with the palliative treatment for unresectable carcinoma of the esophagus over a 15 years period. The available methods, their indications and results are analyzed. EXPERIMENTAL DESIGN: A retrospective study where the palliative methods used, their indication, their complications and the survival of the patients have been analyzed. PATIENTS: A whole of 114 patients with unresectable carcinoma of the thoracic esophagus and esophagogastric junction, have been included. RESULTS: The most widely used palliative method was the Celestine tube and the main indication was the unresectable tumor. Mean survival was 4.6 months, and mean hospital stay was 10 days. CONCLUSIONS: The carcinoma of the esophagus is diagnosed too late. That's why, in most cases, it is unresectable. However, it is important to offer some palliative treatment to the patients to improve, if possible, their quality of life. We suggest that the requirements for a palliative method are the following: easy and quick technique, brief hospital stay, improvement of patient comfort and low morbimortality.
